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ABSTRACT
Avian influenza A viruses have gained increasing attention due to their ability to cross the species barrier and cause severe dis-
ease in humans and other mammal species as pigs. H3 and particularly H3N8 viruses, are highly adaptive since they are found in
multiple avian andmammal hosts. H3N8 viruses have not been isolated yet from humans; however, a recent report showed that
equine influenza A viruses (IAVs) can be isolated from pigs, although an established infection has not been observed thus far in
this host. To gain insight into the possibility of H3N8 avian IAVs to cross the species barrier into pigs, in vitro experiments and
an experimental infection in pigs with four H3N8 viruses from different origins (equine, canine, avian, and seal) were per-
formed. As a positive control, an H3N2 swine influenza virus A was used. Although equine and canine viruses hardly replicated
in the respiratory systems of pigs, avian and seal viruses replicated substantially and caused detectable lesions in inoculated pigs
without previous adaptation. Interestingly, antibodies against hemagglutinin could not be detected after infection by hemagglu-
tination inhibition (HAI) test with avian and seal viruses. This phenomenon was observed not only in pigs but also in mice im-
munized with the same virus strains. Our data indicated that H3N8 IAVs fromwild aquatic birds have the potential to cross the
species barrier and establish successful infections in pigs that might spread unnoticed using the HAI test as diagnostic tool.
IMPORTANCE
Although natural infection of humans with an avian H3N8 influenza A virus has not yet been reported, this influenza A virus
subtype has already crossed the species barrier. Therefore, we have examined the potential of H3N8 from canine, equine, avian,
and seal origin to productively infect pigs. Our results demonstrated that avian and seal viruses replicated substantially and
caused detectable lesions in inoculated pigs without previous adaptation. Surprisingly, we could not detect specific antibodies
against hemagglutinin in any H3N8-infected pigs. Therefore, special attention should be focused toward viruses of the H3N8
subtype since they could behave as stealth viruses in pigs.
The most ubiquitous hemagglutinin (HA) subtype of influenzaA virus (IAV) is the H3, since it can be found in a variety of
organisms, including humans, pigs, horses, dogs, cats, seals, poul-
try, and wild aquatic birds. Among all H3 subtypes, the H3N8 has
turned out particularly interesting since it has established lineages
not only in wild aquatic birds but also in mammalian species such
as horses and dogs. At present, H3N8 is the only IAV subtype
circulating in equine and canine species (1, 2). However, until
now this subtype is not circulating in pigs and humans (1).
Recently, equine H3N8 (clade II) strains have been isolated
from pigs in China (3), but except for this publication no more
data about transmission of equine IAV to pigs has been reported.
Equine IAV has not been reported to cause disease in humans;
however, a study from the 1960s showed that, in fact, humans
were susceptible to equine IAV infection when infected with
A/Equine/Miami/1/63 (H3N8) (4). Also, studies with archeos-
erological samples suggested that the virus circulating in humans
during the 1889 pandemic could belong to the H3N8 subtype (5).
Nevertheless, recent reports showed on one hand, sparse serocon-
version in humans after exposure to equine IAV (6), and on the
other hand, serological evidence of equine IAV infections among
persons with horse exposure (7).
Seals on the coast of Massachusetts were recently dying from
respiratory pneumonia, and the agent responsible for this deadly
event was identified as an H3N8 virus of avian origin (8). The seal
IAV was closely related to an avian strain, A/blue-winged teal/
Ohio/926/2002 (H3N8), with an overall 96.07% nucleotide iden-
tity. This H3N8 seal IAV naturally acquired mutations known to
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increase transmissibility and, subsequently, ferrets were success-
fully infected by respiratory transmission (9).
Since the species barrier for H3N8 IAV might be easily over-
come in nature, we hypothesized thatH3N8 viruses fromdifferent
origins had acquired the ability to replicate and produce lesions/
disease in pigs. Thus, four H3N8 IAVs from different species were
selected to assess the ability to replicate and produce disease in
pigs.
Our results showed that swine, avian, and seal IAVs exhibited
higher replication abilities and differential binding affinities in
vitro than the equine and canine IAVs. Moreover, H3N8 viruses
adapted to equine and canine exhibited negligible replication in
inoculated pigs, and therefore no lesions were found in these an-
imals. Surprisingly, the H3N8 avian virus selected in the present
study, as well as the virus isolated from seals not only replicated
substantially but also caused lesions in the lungs of infected pigs.
Interestingly, we were unable to detect antibodies by hemaggluti-
nation inhibition (HAI) test in animals when infected with the
avian or the seal H3N8 viruses. The absence of antibodies as de-
termined by HAI was also observed in mice immunized with the
same avian and seal viruses.
MATERIALS AND METHODS
Virus. The following viral isolates were used for the in vitro experiments
and the experimental infection: A/Swine/Spain/54008/2004 (H3N2), a
swine IAV strain (Sw); A/Equine/OH/1/03 (H3N8), an equine IAV strain
(Eq); A/Canine/NY/105447/08 (H3N8), a canine IAV strain (Ca);
A/American black duck/Maine/44411-532/2008 (H3N8) (Av); and
A/Harbor Seal/New Hampshire/179629/2011 (H3N8) (Se). Also, a low-
pathogenicity A/Anas plathyrhynchos/Spain/1877/2009 (H7N2) strain, a
pandemic A/Catalonia/63/2009 (H1N1) strain, and a human A/Perth/
16/09 (H3N2) strain were used. Viral stocks were grown in 10-day-old
specific-pathogen-free (SPF) embryonated eggs or in MDCK as stated in
the text.
Mean death time and viral growth. Ten-day-old embryonated eggs
were inoculated with 0.1 ml of Sw, Eq, Ca, Av, and Se viruses containing
104 and 105 50% chicken embryo infectious doses (EID50), respectively.
Three eggs per sample were used. Eggs were candled every 6 h to deter-
mine death over 4 and a half days. The time in hours needed to kill half of
the inoculated embryos for each virus dilution was then calculated. The
mean time to death (MTD) in hours represents the average of three values.
To analyze viral replication, confluent MDCK cells were infected at a
multiplicity of infection (MOI) of 0.001 and incubated for different time
periods at 37°C. Culture supernatants were collected at different time
points, and progeny viruses were determined by plaque assay. Titers were
expressed as the number of PFU per ml.
Hemagglutination assays. Hemagglutination assays were performed
for pigs according to the OIE manual for testing terrestrial animals.
Briefly, red blood cells (RBCs) from chicken, horse, cow, sheep, ferret, pig,
dog, guinea pig, and goat sources were obtained from the experimental
farm at theUniversitat AutonomadeBarcelona (Spain) and kept inAlsev-
er’s solution (Sigma). RBCs from humans were obtained from healthy
volunteers. The RBCs were washed in phosphate-buffered saline (PBS)
and resuspended to 0.5% (chicken) or 0.75% (other species). Viruseswere
diluted to 4 HA units/50 l using chicken RBCs. Serial dilutions of test
sera were then prepared, added to equal volumes of washed RBCs of each
species, and incubated in V-bottom plates. Reaction mixtures were incu-
bated at room temperature for 30 min. The HA titer endpoint was the
reciprocal of the highest dilution that causes complete hemagglutination.
Influenza A virus binding to swine tracheal explants. The tracheas
from two mock-infected pigs were obtained under aseptic conditions.
After the samples were washed with PBS supplemented with penicillin
(100 U/ml), streptomycin (100 g/ml), and gentamicin (100 g/ml),
fragments of about 5 by 5 mm2 were excised and kept on ice until use.
Control tracheal explants devoid of sialic acid residues were prepared by
incubation with neuraminidase (NA; Sigma catalog no. N7885, 10 U/ml)
for 2 h at 37°C. Host receptor binding assays with Sw H3N2, Eq H3N8,
and Ca H3N8 were performed as follows. First, 103 EID50 of each virus
were added to four explants (two from each of two tracheas) in each well
of a six-well plate with 1 ml of culture medium (Dulbecco modified Eagle
medium [DMEM] and RPMI 1640 [1:1]), along with penicillin (100
U/ml), streptomycin (100g/ml), and gentamicin (100g/ml), followed
by incubation for 1 h at room temperature. Neuraminidase-treated con-
trol tracheal explants were also inoculated in parallel. After incubation,
the virus was removed, and the explants were washed 10 times with PBS
with antibiotics and frozen at 80°C. The total RNA from the explants
was isolated with a PureLink RNA minikit (Ambion, catalog no.
12183018A), and an IAV M-gene-based real-time reverse transcription-
PCR (rRT-PCR) was performed in accordance with CDC rRT-PCR pro-
tocols.
Detection of swine influenza in swine tracheal explants. IAV at-
tached to tracheal explants was detected as previously described (10) by
using a Superscript III Platinum One-Step Quantitative RT-PCR system
(Invitrogen, catalog no. 11732-088), including a 25-l reaction, run on a
Corbett Research Rotor-Gene 3000 real-time thermal cycler. The cycle
threshold (CT) values for the rRT-PCR of the different explant and virus
samples were recorded to assess the relative amounts of virus bound to the
tracheal explants that were wither treated and not treated with neuramin-
idase.
IAV proliferation in tracheal explants was detected by infecting two
six-well plates, each containing six tracheal explants, with 106 EID50 of
each strain in 1 ml of infection medium (DMEM-RPMI [1:1]), including
penicillin (100 U/ml), streptomycin (100 g/ml), and gentamicin (100
g/ml), and then treated with trypsin (2 g/ml) for 1 h at 37°C. After
infection, explants were washed six times with 2 ml of PBS, followed by
incubation in 1 ml of infection medium at 37°C. Samples of 150 l of
supernatant were taken at 0, 24, and 48 h postinfection (p.i.) and frozen at
80°C until analysis. Quantification of virus in supernatants was per-
formed by using rRT-PCR as described above and according to the
method of Reed andMuench (11). At each time point after infection, two
explants were taken and fixed with 10% buffered formaldehyde for im-
munohistochemistry analysis.
Animals. All experiments with pigs were conducted at the Centre de
Recerca en Sanitat Animal, Barcelona, Spain, in compliance with the Eth-
ical Committee for Animal Experimentation of the institution (Universi-
tat Autònoma de Barcelona). The treatment, housing, and husbandry
conditions conformed to European Union guidelines (Directive 2010/
63/EU on the protection of animals used for scientific purposes). Animal
care and procedures were in accordance with the guidelines of the Good
Laboratory Practices under the supervision of the Ethical and AnimalWel-
fare Committee of the Universitat Autònoma de Barcelona (approval no.
1189) and under the supervision of the Ethical and AnimalWelfare Com-
mittee of the Government of Catalonia (approval no. 5796). In line with
the above operational framework, six groups of pigs (7 to 8 weeks old,
Landrace Pietrain, free from common pathogens) were housed in sep-
arate isolation rooms and adapted to the new environment and stockmen
over a 1-week period under veterinary supervision. Experiments with
mice (BALB/c strain,Harlan LaboratoriesModels, Spain)were conducted
at the INIA (Instituto Nacional de Investigación y Tecnologša Agraria y
Alimentaria) facilities in Madrid, Spain, in compliance with the Ethical
Committee for Animal Experimentation guidelines of the institution.
Experimental infection. The pigs used in our experiment were sero-
negative to influenza A viruses by competition Elisa (ID Screen Influenza
A Antibody Competition ELISA; ID-Vet, France) at the time of the exper-
iment. Five groups of 12 pigs were infected with IAV strains SwH3N2, Eq
H3N8, Ca H3N8, Av H3N8, and Se H3N8, respectively. Six pigs were
mock infected.
On day 0, each pig in all groups but the mock-treated group was
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intratracheally infected with 1ml of virus containing 2 105 EID50 of the
corresponding virus strain. Animals were clinically inspected, and the
rectal temperature was recorded on a daily basis. Four pigs of each virus-
infected group were euthanized and weighed at 3, 6, and 21 days p.i.,
respectively. In the mock-infected group, two pigs were euthanized and
weighed at each of the same times. For all of the animals, the average daily
weight gain was recorded as the difference between the final and initial
weights (day 0 p.i.) divided by the number of days postinfection (dpi).
Samplings and postmortem examination.Nasal swabs were taken at
days 1, 2, 4, 8, and 10 p.i. They were frozen for viral determination. Ve-
nous blood samples in vacuum tubes were collected at day 0 and just
before sacrifice on the aforementioned days. After sacrifice, bronchoal-
veolar fluids (BALF) were collected via lung lavage with PBS, as described
by Busquets et al. (12). Briefly, the right lungs of sacrificed pigs was used to
perform a bronchoalveolar lavage (BAL) using approximately 100 ml of
PBS, and the left one was sampled for histopathological and virological
studies. A complete necropsy was performed. Lung lesions were classified
depending on the extension of pneumonia. Mild lesions were recorded
when affecting small areas (2 cm2) of cranial ormedial lung lobes, mod-
erate lesions were recorded when affecting extended areas (2 to 5 cm2) of
cranial or medial lobes, and severe lesions were recorded when affecting
large areas (5 cm2) of cranial, medial, diaphragmatic, and accessory
lobes.
Histopathology and immunohistochemistry. Samples from trachea
and lungs were collected, fixed in 10% buffered formalin, and processed
for histopathology, i.e., they were dehydrated through graded alcohols
and embedded in paraffin. Sections (3 m thick) were cut, stained with
hematoxylin-eosin, and examined in a “blind fashion.” In particular,
bronchiolar epithelial changes and peribronchiolar inflammation was
evaluated in large, medium, and small or terminal bronchioles, as well as
inflammatory changes in alveoli. In the lung, bronchointerstitial pneu-
monia intensity was assessed bymeans of semiquantitative lesion scoring.
The pathological scores for tracheal and pulmonary tissues were as fol-
lows, depending on the extension of the inflammation: 0, no lesions; 1,
mild lesions; 2, moderate lesions; and 3, severe lesions. Immunohisto-
chemistry was used to detect influenza A virus nucleoprotein (NP) ac-
cording to previously described methods (13).
IAV titration.Nasal swabs were collected and tested to the determine
virus load as described by Busquets et al. (12). Lung homogenates were
prepared by grinding the tissue; homogenates were suspended in 1 ml of
PBS, and tissue debris was removed by low-speed centrifugation. Virus
titers were determined by serial 10-fold dilutions in PBS and inoculation
into the allantoic cavities of five 10-day-old SPF chicken embryos. Sam-
ples were tested for influenzaA virus by using a real-timeRT-PCR (14) for
influenza A matrix gene.
Antibody assays. Serum samples collected frompigs killed at days 3, 6,
and 21 were tested for antibodies against the NP of influenza A virus (ID
Screen Influenza A Antibody Competition ELISA; ID-Vet, France). BALF
and serum collected from pigs killed at days 3, 6, and 21 were tested for
antibodies against NP of influenza A virus using the same ELISA. 1/10 and
1/20 dilutions of each sample were examined according to the method of
de Boer et al. (15). Samples were considered positive if at least 75% inhi-
bition was detected at either dilution.
TheHAI test was performed on pig sera collected at days 0, 3, 6, and 21
against the respective homologous IAV strains according to the directions
of theOIEManual of Diagnostic Tests and Vaccines for Terrestrial Animals
(16). Heterologous swine and equine IAV were also used in HAI tests
(swine IAVs H1N1 A/sw/It/267505, H1N2 A/sw/It/284922/09, andH3N2
A/sw/It/312583/09 and equine IAV H3N8 A/eq/New Market/93).
A neuraminidase inhibition assay was performed according to recom-
mended World Health Organization protocols (17) and is based on the
ability of antisera to inhibit the activity of the NA enzyme of IAV deter-
mined by the release of free sialic acid from a fetuin substrate (18). The
amount of free sialic acid was measured in a spectrophotometer at 549
nm, and one unit of NA activity was determined as the dilution of virus
that gave an optical density reading of 0.500 under standard conditions.
Serum dilutions from pigs infected with each indicated virus, collected 21
days p.i., were preincubated for 60min at room temperaturewith one unit
of NA activity of the corresponding virus. The percentage of NA activity
not neutralized by antiserum, with respect to the negative control, was
plotted against an antiserum dilution.
A virus neutralization assay was performed according to recom-
mended World Health Organization protocols (17) with the following
modifications. Briefly, 50 l of a stock solution (2,000 50% tissue culture
infective doses [TCID50]/ml) of virus was mixed with 50 l of 2-fold
dilutions of sera. After 2 h of incubation at 37°C, virus-serum mixtures
were added to 96-well microtiter plate containing MDCK cells (120,000/
0.050ml/well). To detect viral infection, each well was observed at micro-
scope after 80% acetone fixation for 48 h at 20°C and staining with a
nucleoprotein IAV monoclonal antibody (ATCC hb65) conjugate with
peroxidase. Titers for the SN assays were reported as the reciprocal of the
last serum dilution that completely inhibited infection of MDCK cells.
Immunization of mice. BALB/c female, 8-week-old mice (four mice
per group) were inoculated intraperitoneally on days 0 and 14 p.i. with
2.7 107 EID50 or 6 HA units per mouse of Sw H3N2, Av H3N8, and Se
H3N8 IAVs inactivated by UV radiation. For UV inactivation, 0.5 ml of
the virus stocks were placed in a 12-well plate and exposed to 4,000 ergs/
cm2 from a UV source for 15 min at 4°C. Inactivation of viruses was
confirmed by the inoculation of three 10-day-old embryonated chicken
eggs with 100 l of each UV-treated stock virus. A control group of non-
immunized mice was used for comparison.
Blood samples were collected 2 weeks after the second immunization,
and sera previously treated at 56°C for 1 h and with receptor-destroying
enzyme (Sigma-Aldrich, St. Louis, MO) at 37°C overnight were analyzed
by enzyme-linked immunosorbent assay (ELISA) and HAI testing. Titers
of anti-influenza A virus antibodies of mice sera were tested in a home-
made ELISA using microplates coated with 2 g of purified A/PR/8/34-
H1N1 strain/ml. HAI titers were assayed as previously described for swine
sera and according to established protocols (16).
Viral genome sequence. Viral RNA was extracted from samples by
using a QIAamp viral RNA minikit according to the manufacturer’s in-
structions (Qiagen). RT-PCR analyses of all eight genome segments was
performed as described by Lycett at al. (19) using the SuperScript III
One-Step RT-PCR system with Platinum High Fidelity Taq (Invitrogen).
RT-PCR products were purified with NucleoSpin gel and PCR Cleanup
(Macherey-Nagel). DNAwas quantified using a Sinergy H1 hybrid reader
(Bio-Tek). Indices were added, andmultiplexedDNA libraries weremade
with aNextera-XTkit (Illumina) according to themanufacturer’s instruc-
tions. Pooled libraries were sequenced on aMiSeq Instrument (Illumina)
by using a Miseq reagent kit (v2) in a 250-cycle paired-end run. The data
were de novo assembled on cloud on Base Space (BaseSpace; Illumina) by
the DNASTAR application and analyzed by the Lasergene Package soft-
ware (v10.1.2).
Full genome sequences obtained or retrieved from GenBank were
aligned byCLUSTALWusingMEGA5, and treeswere produced using the
neighbor-joining method with a 1,000-replicate bootstrap. The evolu-
TABLE 1Mean time to deatha
Influenza virus
Mean time to death (h) SD
104 EID50 10
5 EID50
Sw 50 7.5 50 2.8
Eq 108 108
Can 108 108
Av 60 4.9 58 5.6
Se 96 8.5 96 4.9
a Three ten-day-embryonated chicken eggs were inoculated with 104 and 105 50% egg
infective doses (EID50) of swine (Sw), equine (Eq), canine (Ca), avian (Av), or seal (Se)
influenza viruses. Eggs were candled every 6 h to determine death over 4.5 days.
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tionary distances were computed using the Kimura two-parameter
method with bootstrap test (1,000 replicates). Sequences of eight gene
segments of the seal, avian, and swine viruses, before and after the repli-
cation in pigs were aligned, respectively, by CLUSTAL W using MEGA5
(20). The predicted amino acid sequence was obtained for each gene, and
a comparison between the proteins before and after the infection was
performed.
Statistical analysis. All statistical analysis was performed using SPSS
15.0 software (SPSS, Inc., Chicago, IL). For all analyses, each animal (pig
or mouse) was used as the experimental unit. The significance level (	)
was set at 0.05, with statistical tendencies reported when P was0.10. A
nonparametric test (Kruskal-Wallis) was chosen to compare the values
obtained for the viral load, antibody titer, body temperature, and average
daily gain between the different viruses used for the in vivo experiment.
This same statistical tool was also used to compare the viral load deter-
mined for the in vitro experiment for the different groups. Finally, a Fisher
exact test was used to test the association between histopathological
scores, macroscopic lesions, and the different viruses used for the in vivo
experiment, respectively.
RESULTS
Swine, avian, and seal IAVs exhibited higher replication abili-
ties in vitro than the equine and canine IAVs. First, replication of
the different H3N8 IAVs was analyzed in vitro. Replication in dif-
ferent substrates (embryonated chicken eggs and MDCK cells)
was performed successfully by all viral strains except the canine
IAV. The canine strain was not able to grow in MDCK cells, al-
though different cell batches were tested. Also, the equine strain
grew very poorly. Since all viruses replicated in eggs, they were
grown in 10-day-embryonated eggs, and titers were determined
by EID50 to standardize the virus stocks. The obtained virus titers
were: swine (Sw), EID50/ml 5.6 10
7; equine (Eq), EID50/ml
5.6  107; canine (Ca), EID50/ml  3.2  10
7; avian (Av),
EID50/ml  3.2  10
8; and seal (Se), EID50/ml  5.6  10
8. In
order to compare the abilities of these viruses to kill embryonated
eggs, 9-day-embryonated eggs were inoculated with two different
doses (104 and 105 EID50, respectively), and the mean time to
death (MTD) for each viral strain was measured (Table 1). Al-
though the Eq and Ca viruses were not able to kill the eggs in 108
h, theMTD for Sw IAVwas
50 h, that for Av IAVwas 58 to 60 h,
and that for Se IAV was
96 h.
Subsequently, the growth of the Av and Se H3N8 viruses was
compared to that of Sw H3N2 virus onMDCK cells infected at an
MOI of 0.001 (Fig. 1A). The Eq and Ca viruses were not included,
since replication in MDCK cells was undetectable. All tested vi-
ruses grew in MDCK cells reaching similar titers (Fig. 1A), al-
though the Sw IAV showed a faster replication in this substrate.
Then, 150-l portions were taken at each time point and used to
assess the virus titers by a plaque assay. Remarkably, Sw IAV
formed the largest plaques, followed by theAv IAV; Se IAV yielded
the smallest plaques of the three viruses (Fig. 1B).
Equine, canine, avian, and seal IAVs exhibited different
binding affinities to a broad repertoire of RBCs. IAV viruses
bind to cell surface sialyloligosaccharides with specificities that
vary according to the host species of origin. A rough method to
determine receptor specificity of IAV is to measure the ability of
these viruses to hemagglutinate different RBCs, as it has been pre-
viously shown (21). A panel of RBCs from different sources were
FIG 1 (A)MDCK viral growth in vitro of swine (Sw), avian (Av), and seal (Se)
IAVs. (B) Plaque sizes of Sw, Av, and Se IAVs on MDCK cells.
TABLE 2 Hemagglutination activity of Sw H3N2, Eq H3N8, Ca H3N8, Av H3N8, and Se H3N8 influenza viruses with erythrocytes from different
animalsa
Influenza virus
HA titer endpoint (g/ml)
Horse Cow Sheep Ferret Human Pig Dog Guinea pig Goat
Sw H3N2 32 2 4 4 16 4 16 16 2
Eq H3N8 32 32 16 16 16 4 32 16 8
Ca H3N8 32 32 16 16 16 8 32 16 4
Av H3N8 32 32 16 32 16 16 32 16 8
Se H3N8 32 64 32 16 16 32 16 16 16
H7N2(LP) 32 16 16 16 16 16 16 16 4
pdmH1N1 8 2 8 16 16 2 16 16 2
H3N2 2 2 2 32 16 2 16 16 2
MAAII 256 2 32 128 128 4 256 128 2
SNA 16 2 2 256 256 256 64 256 2
a Red blood cells (RBCs) from horse, cow, sheep, ferret, human, pig, dog, guinea pig, and goat sources were washed in PBS and resuspended to 0.75%. Viruses were diluted to 4 HA
units established on chicken RBCs. Serial 2-fold dilutions of viruses were then prepared, added to equal volumes of washed RBCs of each species, and incubated in V-bottom plates.
Reaction mixtures were incubated at room temperature for 30 min. The HA titer endpoint is the reciprocal of the highest dilution that caused complete hemagglutination.
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used to investigate the avidity of our H3N8 IAV, as well as of the
Sw H3N2 IAV. As a control, two lectins with proven different
receptor specificity were used. Maackia amurensis lectin II
(MAAII) binds sialic acid in an 	-2,3 linkage. On the other hand,
Sambucus nigra lectin (SNA) prefers structures with 	-2,6-linked
sialic acid (22). Another two human influenza A viruses, A/Cata-
lonia/63/2009 (H1N1) and A/Perth/16/09 (H3N2), were used for
comparison with the viruses under study. In addition, we also
tested an unrelated low-pathogenicity IAV from a different sub-
type, A/Anas plathyrhynchos/Spain/1877/2009 (H7N2; accession
no. KP636483 to KP636490) (23) (Table 2).
Chicken RBCs were bound by all IAV tested (data not shown),
and we standardized the assay to four HA units of virus using
chicken blood (the limited HA activity was determined by the low
titer of the Ca IAV). Horse and cow RBCs have been reported to
have predominant expression of 	-2,3-linked sialic acids, and
therefore human IAVs do not bind, whereas avian viruses do.
Our results clearly correlated with the previous reported obser-
vations since the human viruses bind with no or low avidity to
horse and cow RBCs. Strikingly, whereas MAAII binds with
stronger avidity to equine RBCs, its binding to cow RBCs was
completely negative in contrast to H3N8 and H7N2 viruses.
The binding avidity to guinea pig and human RBCs was indis-
tinguishable among all viruses tested and, in fact, both lectins,
although at a higher avidities, bound in a similar way. RBCs
from pigs could be agglutinated by all H3N8 viruses but not by
the human viruses tested. Our lectin control showed that SNA
could bind with a high efficiency; however, our two human IAV
could not bind. Although swine and human IAVs showed dis-
tinct avidities when using different RBCs, the H3N8 viruses,
particularly the Av and Se viruses, could bind to a wide reper-
toire of RBCs with similar avidities, i.e., to a broader range of
sialic acids (Table 2).
Equine, canine, avian, or seal IAVs exhibited different bind-
ing and replication abilities in pig tracheal explants.One of the
steps that IAVs must overcome to infect the respiratory tract in
the host is to bind and replicate in the tracheal epithelium. Thus,
the ability of the four H3N8 and swine IAVs to bind and replicate
in swine tracheal explants was addressed in vitro (Tables 3 and 4).
IAV binding to tracheal explants versus binding to explants de-
void of sialic receptors by neuraminidase treatment gave us quan-
titative evidence of specific virus binding to its receptor. Sw IAV
showed the strongest specific binding to swine tracheal explants,
followed by the Av and Se IAVs. Eq andCa IAVs, however, did not
show specific binding to explants (Table 3). A statistical tendency
(P  0.08) was observed in the binding ability between all of the
pairs of viruses included in the study with the exception of Av/Se
and Sw/Se. The proliferation of Sw, Eq, Av, and Se IAVs was also
measured on supernatants of swine explants by determining the
TCID50 and by quantitative RT-PCR (qRT-PCR) (Table 4). Swine
IAV and, to a lesser extent, the Av and Se IAVs were able to repli-
cate in swine tracheal explants. However, Eq and Ca IAVs did not
exhibit any measurable replication.
Equine, canine, avian, or seal IAVsdiffer in their pathogenic-
ity in pigs. In order to gain insight into the ability of these viruses
to cross species barrier and establish an infection into a mamma-
lian host, groups of 12 pigs were infected with each of the five H3
IAV plus six mock-infected animals. None of the infected pigs
showed respiratory signs after infection (data not shown) with the
exception of fever in some animals belonging to the Sw and Av
infected groups from days 2 to 4 p.i. (Fig. 2). The highest percent-
age of animals with fever was observed at day 3 p.i., and this per-
centage was significantly different between the Sw infected group
and the rest of viruses, with the exception of the avian group,
where a statistical tendency was observed (P  0.08). No signifi-
cant differences were observed in the average daily weight gain
(ADWG) between pigs infected with different viruses at the dif-
ferent time points, but the lowest ADWGwas observed for the Sw
infected group (data not shown).
At 3 days p.i., macroscopic lesions were not observed in the
lungs of pigs infected with the equine and canine IAVs nor in the
mock-infected group. Extended areas of lung consolidation af-
fecting 50% of both cardiac lobes and a small portion of right
diaphragmatic lobe could be observed in swine IAV-infected an-
imals. Interestingly, infection with Av and Se IAVs, on the other
hand, resulted in multifocal areas of lung consolidation affecting
25%of both cardiac lobes (Fig. 3).Moreover, themacroscopic and
microscopic lesions observed for the different viruses were signif-
icantly different (P  0.05) between them. At 6 dpi, a pattern of
TABLE 3 Binding of influenza viruses on swine tracheal explantsa
Influenza virus
Mean CT  SD
CT
Without
neuraminidase
With
neuraminidase
Sw 37.14 1.73 40.14 1.01 3.00
Eq 39.75 0.15 39.88 0.3 0.13
Ca 41.01 0.31 42.32 0.65 1.31
Av 38.74 0.51 41.44 0.54 2.70
Se 38.62 0.74 40.83 094 2.21
a CT, cycle threshold values of matrix-based RT-PCRs of neuraminidase-treated or
nontreated swine tracheal explants incubated in vitro with different influenza viruses.
The means of six infected explants examined for each virus are shown.
TABLE 4 Virus proliferation on tracheal explants: CT and log TCID50 values
Influenza virus
Mean CT  SD
a Log TCID50
b
0 hpi 24 hpi 48 hpi Inoculum 0 hpi 24 hpi 48 hpi
Sw 39.40 1.21 28.20 1.35 26.50 1.82 2.75 0.00 3.25 4.25
Eq 39.84 0.74 39.34 1.07 40.04 1.62 2.25 0.00 0.00 0.00
Ca 40.08 0.86 39.59 1.22 41.38 1.93
Av 39.12 1.23 30.66 1.85 28.20 0.86 4.00 0.00 3.20 1.37
Se 40.02 1.42 32.40 1.53 31.08 1.87 4.00 0.00 2.25 2.70
a CT, cycle threshold values of matrix-based RT-PCR of supernatants of swine tracheal explants Means of supernatants from six infected explants for each virus are shown.
b The virus concentration in supernatants from infected tracheas was measured in MDCK cell cultures at different time points. Note that canine H3N8 IAV does not proliferate on
MDCK cells.
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lung consolidation similar to the one observed at 3 dpi was ob-
served in euthanized pigs. Finally, at 21 dpi, most pigs showed
healed lungs, including the presence of scars in some cases (a find-
ing reminiscent of a previous infection) (data not shown).
Histopathological and immunohistochemical studies further
corroborated gross macroscopic lesions in the lungs (Table 5 and
Fig. 4). Pulmonary lesions were consistent with bronchointersti-
tial pneumonia at different grades of severity. This lesion con-
sisted of a lymphoplasmacytic infiltration in the bronchioli with
extension to the surrounding alveolar septa. In the most severe
cases, at 3 days p.i., necrosis of the bronchiolar epithelium was
observed, with accumulation of necrotic cells in the bronchiolar
lumen and alveolar spaces. Tracheal lesions consisted of variable
grades of lymphoplasmacytic infiltration in the lamina propria; in
the most severe cases, focal ulceration of the mucosa with fibrin
deposition and neutrophilic infiltration was observed (data not
shown). Immunohistochemical staining of the IAV was observed
in the nuclei of tracheal and bronchiolar epithelial cells, pneumo-
cytes, and alveolar macrophages. Positive staining was abundant
in the most severe cases; however, only a few cells were positive in
moderate lesions. No positive staining was detected in mild cases.
Avian and seal IAV viruses replicated andmaintained infec-
tions in the lungs of pigs without shedding. The ability of these
IAV strains to replicate in lungs was investigated by analyzing
EID50 virus titers in tissues. In parallel, using a different sample
from the same infected area, the viral concentration was also de-
termined by qRT-PCR (Table 6). The highest virus titers were
obtained within the Sw virus-infected group at day 3 in the range
of 106 to 107 EID50/ml. Biological titers correlated with the qRT-
PCR data. At day 6, two of four animals still had detectable EID50
virus titers in the range of 102 EID50/ml, although viral RNA was
also detected in samples at 6 dpi from all of the four pigs. Except
FIG 2 Percentage of animals with fever (40°C) after IAV inoculation.
Twelve pigs by group were inoculated with swine-origin avian, seal, equine,
and canine H3N8 IAVs. Six or twelve animals were mock infected or infected
with H3N2 IAVs, respectively. The temperature was recorded daily. The data
shown are averages from all animals per group.
FIG 3 Macroscopic pulmonary lesions observed at 3 dpi in pigs inoculated with different IAVs. (A) Control. Note the absence of lesions. (B) Swine (Sw) IAV.
There are extended areas of pneumonia (arrows) affecting 50% of both cardiac lobes and a small portion of the right diaphragmatic lobe. (C) Equine (Eq) IAV.
Note the absence of lesions. (D) Canine (Ca) IAV. Again, note the absence of lesions. (E) Avian (Av) IAV. There aremultifocal areas of pneumonia affecting 25%
of both cardiac lobes (arrows). (F) Seal (Se) IAV. There are multifocal areas of pneumonia affecting 25% of both cardiac lobes (arrows).
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for one animal in the Eq and Ca virus-infected groups with an
extremely low virus titer, the presence of viral replication in the
lungs of pigs infected with these viruses was undetectable. These
results correlated with the absence of lesions in the lungs (Fig. 3)
and the data from binding and replication in trachea explants
(Tables 3 and 4). The Se IAV replicated to a certain extent in the
lungs of pigs, between 102 and 103 EID50/ml at day 3 p.i. Signifi-
cant differences (P  0.05) were observed in the ability of these
viruses to replicate in the lungs between all pairs of viruseswith the
exception of the Sw/Av and Sw/Se IAVs. At day 6, the presence of
the virus in one animal as determined by EID50 and in two animals
by as determined by qRT-PCR was still detectable. Finally, the Av
IAV replicated substantially in the lungs of pigs reaching virus
titers up to 104 EID50/ml at day 3 p.i. At day 6, the presence of the
virus in one infected animal was still detectable. All animals
cleared the infections by day 21 since all samples became negative
in both virological and molecular tests. The presence of the virus
in the BALFs was also checked in embryonated eggs and by qRT-
PCR. A good correlation was observed between the virus titers in
lungs and the qRT-PCR results for BALF samples (Table 6). On
the whole, these results indicated that the selected H3N8 viruses
from a wild aquatic reservoir can infect and cause lesions in the
respiratory tracts of pigs without previous adaptation.
In addition, nasal swabs from infected animals were taken ev-
ery other day for 10 days in a row to assess viral shedding. Viral
shedding was only detected in the Sw IAV-infected group, but it
was not detected in the rest of pigs. In fact, at day 2 p.i., only 3 of 12
animals shed virus, and at day 4 p.i. only 4 of 8 animals shed virus
(data not shown).
Pigs infected with H3N8 avian IAVs had undetectable anti-
bodies in theHAI test.All pigs at the beginning of this experiment
were seronegative for IAV, as determined by a IAV blocking
ELISA against NP (data not shown). All infected animals except
themock-infected group seroconverted against NP protein by day
21 p.i. (Table 7). Even pigs infected with the Eq and Ca IAVs that
did not have a detectable infection showed antibodies against NP.
TABLE 5 Pathological and immunohistochemical analyses of tracheal and lung tissue from controls and pigs infected with different influenza
virusesa
Time point
(days)
Score
Control Swine Equine Canine Avian Seal
T L T L T L T L T L T L
3 0 – 0 – 1.5  2.25  0.25 – 0.5 – 0.25 – 0 – 1.25 – 2  1 – 1.75 
6 NP NP NP NP 1.5 NP 0.25 NP NP NP NP NP NP NP NP NP 1.25 NP 0.5 NP 1.5 NP 0.5 NP
21 NP NP NP NP 0 – 0 – NP NP NP NP NP NP NP NP 0.75 – 0.75 – 0.25 – 1.25 –
a For each tissue, the pathological score varied from 0 to 3; the data represent the averages for each group (four animals), except for the controls (two animals). For
immunohistochemistry, the detection of influenza antigen in the group is indicated (/–). T, trachea; L, lung; NP, not performed.
FIG 4 Immunohistochemical detection of IAV antigen at 3 dpi in the lungs of pigs infected with different IAVs. (A)Negative control. (B) Swine (Sw) IAV. There
is positive nuclear staining in a few epithelial and desquamated cells of the bronchioli. (C) Equine (Eq) IAV. Note the negative staining. (D) Canine (Ca) IAV.
Note the negative staining. (E) Avian (Av) IAV. There is positive nuclear staining in a few epithelial cells of the bronchioli. (F) Seal (Se) IAV. There is positive
nuclear staining in a few epithelial cells of the bronchioli.
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All of the Se IAV-infected animals and three of four in the Sw and
Av IAV groups were positive for NP antibodies at day 6 pi. In the
Eq and Ca IAV-infected groups, only one animal in each group
was NP positive at this time point. All sera were tested for their
ability to inhibit neuraminidase (NA) function as a measurement
of the specific antibodies against NA. The data in Fig. 5 indicated
that these antibodies were indeed present in pigs infected with Sw,
Av, and Se viruses, whereas they were absent in themock-infected
pigs and the ones belonging to the Eq or the Ca virus groups.
Finally, significant differences (P  0.05) were observed in anti-
body titers against NA between the Sw/Av/Se viruses and the Eq/
Ca/Mock groups.
Subsequently, antibodies against HA were measured using
HAI, the reference assay for antibody detection for IAV infections
(Table 7). Unexpectedly, we could only detect antibodies against
its own HA (homologous HAI) at day 21 p.i. in the swine IAV-
infected group.We could not detect antibodies in the other groups
TABLE 6 Virus titers obtained by egg inoculation and real-time PCR results for lungs and bronchoalveolar lavage fluids collected from infected pigsa
Virus
Virus titer (EID50/ml) in lungs RT-PCR (CT) result in BALF
Day 3 Day 6 Day 21 Day 3 Day 6 Day 21
Mock-1 0/0 0/0 0/0 0 0 0
Mock-2 0/0 0/0 0/0 0 0 0
Sw-1 107/18 102/25 0/0 26 32 0
Sw-2 (5.6 106)/19 102/27 0/0 25 26 0
Sw-3 (5.6 106)/17 0/31 0/0 26 29 0
Sw-4 106/19 0/31 0/0 21 33 0
Eq-1 0/0 0/0 0/0 35 0 0
Eq-2 0/0 0/0 0/0 0 0 0
Eq-3 0/0 0/0 0/0 0 0 0
Eq-4 0/0 0/0 0/0 0 0 0
Ca-1 0/0 0/0 0/0 0 0 0
Ca-2 0/0 0/0 0/0 0 0 0
Ca-3 0/0 0/0 0/0 0 0 0
Ca-4 0/0 0/0 0/0 0 0 0
Av-1 (2.8 104)/28 0/0 0/0 0 0 0
Av-2 10/30 10/30 10/0 0 0 0
Av-3 (4.5 103)/21 0/0 0/0 32 0 0
Av-4 (2.8 103)/32 0/0 0/0 0 0 0
Se-1 (2.8 102)/34 0/0 0/0 0 0 0
Se-2 (4.5 103)/31 10/34 0/0 36 0 0
Se-3 10/36 0/31 0/0 37 37 0
Se-4 (2.8 103)/34 0/0 0/0 33 0 0
a BALF, bronchoalveolar lavage fluid.
TABLE 7 Serological results obtained by HI and NP ELISA
Virus
Titer at various times postinfectiona
Day 3 (HI)
Day 6 Day 21
HI NP ELISA HI NP ELISA
Mock-1 20 20 Neg 20 Neg
Mock-2 20 20 Neg 20 Neg
Sw-1 20 20 Pos 160 Pos
Sw-2 20 20 Neg 160 Pos
Sw-3 20 20 Pos 80 Pos
Sw-4 20 40 Pos 40 Pos
Eq-1 20 20 NC 20 Pos
Eq-2 20 20 Neg 20 Pos
Eq-3 20 20 Neg 20 Pos
Eq-4 20 20 Pos 20 Pos
Ca-1 20 20 Neg 20 Pos
Ca-2 20 20 Pos 20 Pos
Ca-3 20 20 Neg 20 Pos
Ca-4 20 20 Neg 20 Pos
Av-1 20 20 Neg 20 Pos
Av-2 20 20 Pos 20 Pos
Av-3 20 20 Pos 20 Pos
Av-4 20 20 Pos 20 Pos
Se-1 20 20 Pos 20 Pos
Se-2 20 20 Pos 20 Pos
Se-3 20 20 Pos 20 Pos
Se-4 20 20 Pos 20 Pos
a The serological titer is expressed as the reciprocal of the serum dilution. Neg, negative;
Pos, positive; NC, not conclusive.
FIG 5 Neuraminidase (NA) inhibition by sera from pigs infected with each of
the indicated IAVs. The data are means  the standard deviations (SD) for
four sera collected 21 days p.i. from animals inoculatedwith swineH3N2 (Sw),
avian H3N8 (Av), seal H3N8 (Se), equine H3N8 (Eq), and canine H3N8 (Ca)
IAVs and two sera from mock-infected pigs.
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against the each virus even if the assay was repeated three times on
three different days with differently treated samples. The titers
ranged from 1:113 to 1:452 in the Sw IAV-infected pigs. Similar
results were obtained in neutralization tests, since only sera from
pigs infected with the swine-adapted virus strain showed the abil-
ity to neutralize the homologous virus (data not shown).
Sera from animals in different IAV-infected groups were also
tested for cross-reactivity against different swine (H3N2 A/sw/It/
312583/09,H1N1A/sw/It/267505, andH1N2A/sw/It/284922/09)
and equine (H3N8 A/eq/NewMarket/93) IAVs. No cross-reactiv-
ity was detected by HAI testing in any sera, except for those com-
ing from Sw IAV-infected animals, which showed HAI titers with
an H3N2 subtype (data not showed).
Since failure to mount an HAI response was detected in NP-
positive pigs infected with these viruses, the question was whether
or not these results were peculiar to a particular animal species.
Therefore, mice were intraperitoneally inoculated with the inac-
tivated Sw, Av, and Se IAVs at a 2.8 107 EID50 were studied for
antibody generation. All mice seroconverted when ELISA was
used to determine the presence of antibodies against IAV in sera
(Fig. 6A and B). However, Av and Se virus-inoculated mice did
not show HAI antibodies. After the mice were boosted with a
second dose, the Av virus-inoculated mice remained HAI nega-
tive, but some HAI titer seroconversion was observed in the Se
virus-inoculated group (Table 8).
Analysis of the H3N8 avian IAV does not reveal mammalian
adaptation signatures. The Sw H3N2, Eq H3N8, and Se H3N8
IAVs had been previously sequenced, and data were available at
the NCBI database.We sequenced the Ca and Av IAV used for the
experimental infection (accession numbers KP636491 to
KP636498 and KP636475 to KP636482, respectively). Also, iso-
lates from Sw, Av, and Se IAV strains detected in the lungs of
infected pigs were sequenced. The Se IAV did not show any amino
acid changes after replication in pigs, whereas Sw IAV detected in
an infected pig showed an amino acid change D101N in the NP
gene frequently observed in animal IAV (24). On the other hand,
the Av H3N8 virus did not reveal mammalian adaptation signa-
tures. However, the predicted amino acid sequence of HA showed
a S110F mutation (H3 numbering), while the NA sequence
showed a P152S mutation. The significance of these mutations
requires further investigations since neither has been studied
thoroughly. Phylogenetic trees of all eight segments confirmed the
relationship between the avian and seal H3N8 viruses and the
swine H3N2 virus (for seven segments, excluding the NA gene),
which segregated separately from the equine and the canine vi-
ruses (Fig. 7).
DISCUSSION
The emergence and pandemic spread of the 2009 swine origin
H1N1 IAV, despite the ongoing circulation of human H1N1 vi-
ruses, indicates that an antigenically distant animal origin, such as
H3 virus, may pose a pandemic threat despite the circulation of
H3N2 viruses in humans since 1968. On the other hand, even
though direct transmission of Eq H3N8 IAV to humans has not
been reported, infection of humans with Eq IAV under experi-
mental conditions has been proven productive (4). The fact that
Eq IAVs have the ability to infect humans and that these viruses
FIG 6 ELISAs were performed using purified A/PR/8/34 IAVs and sera of
mice immunized intraperitoneally with 2.7  107 EID50 per mouse of swine
H3N2 (Sw), avianH3N8 (Av), and sealH3N8 (Se) IAVs inactivated byUV. (A)
ELISAs were performed using sera collected 9 days after the first immuniza-
tion. (B) ELISA were performed using sera collected 14 days after the second
immunization with the same amount of immunogen. The data are presented
as the median the SD.
TABLE 8 Hemagglutination inhibition assay of sera from mice immunized intraperitoneally with swine H3N2 (Sw), avian H3N8 (Av), or seal
H3N8 (Se) influenza viruses inactivated by UV irradiationa
Serum
Mean titer SD
HI 	-Sw-IV HI 	-Av-IV HI 	-Se-IV
Preboost Postboost Preboost Postboost Preboost Postboost
	-Sw 160 0.0 806.3 284.4 20 20 20 20
	-Av 20 20 20 20 20 20
	-Se 20 20 20 20 20 53.3 23.1
Mock 20 20 20 20 20 20
a Preboost, HI titers for sera collected 9 days after the first immunization; Postboost, HI titers for sera collected 14 days after the second immunization.
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FIG7 Neighbor-joining trees of eight gene segments of viruses examined in the present study () andH3N8 IAVs from equine (Eq), canine (Ca), and avian (Av)
origins retrieved from GenBank.
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have crossed the species barrier and infected dogs, pigs, and cam-
els (25) emphasizes the potential threat posed to human health by
viruses of this subtype. In addition, pigs may be easily exposed to
equine or canine IAV fromhorses anddogs living in the same farm
or after exposure to viruses from birds. Pigs were originally
thought to be the mixing vessel where viruses from different ori-
gins could coinfect the host and new viruses with pandemic po-
tential could arise (26).
The main aim of our study was to investigate the prospective
ability of different H3N8 IAVs from different origins (Eq, Ca, Av,
and Se) to productively infect pigs as a host for possible future
reassortants with pandemic potential. A/Equine/1/OH/03 (H3N8)
was chosen as the representative strain in North America for
equine IAV belonging to clade I. This strain is currently the com-
ponent of the equine influenza A virus vaccine for North America
(2). Since the representative canine IAV for the canine influenza A
virus vaccine is not available, a canine IAV strain was randomly
selected to perform these experiments (A/Canine/NY/105447/08).
A/American black duck/Maine/44411-174/2008 (H3N8)was chosen
as an avian virus representative. The reason to choose this isolate
was based on the experimental data on the binding ability of this
virus to 	-2,6 sialic acids (8). Finally, the seal virus A/Harbor
Seal/New Hampshire/179629/2011 (H3N8) was included since it
caused a fatal outbreak in seals and also for its ability to bind to
mammalian IV receptors (8, 9). As positive control, we used a
swine IAV belonging to the H3N2 subtype (A/Swine/Spain/
54008/2004). This particular strain was isolated from an infected
pig in a Spanish farm.
First, we evaluated the replication and binding abilities in vitro
of an H3N8 set of viruses, and marked differences were observed
among them. Subsequently, their hemagglutination abilities were
studied to confirm sialic acid binding preferences by testing for
their ability to bind to 	-2,6 and 	-2,3 linkages to galactose (re-
ceptors preferred by human and avian IAVs, respectively) in
erythrocytes from several species preferentially expressing 	-2,6
or 	-2,3. On the whole, Eq and Ca viruses were the ones with the
poorest ability to bind to pig erythrocytes (Table 2). Also, they
were the ones with lower binding values to pig trachea explants
and therefore the ones exhibiting the lowest values of viral repli-
cation (Tables 3 and 4). Recent results from Feng et al. (27) ana-
lyzing other related H3N8 canine and equine viruses indicated
that canine and equine viruses show minimal biological differ-
ences despite phylogenetic divergence. In fact, both virus types
bind more effectively to 	-2,3-linked sialic acid than to 	-2,6-
linked sialic acid. These results are in agreement with the findings
presented in here. Feng et al. showed that inoculation of both
viruses into tracheal explants yielded similar levels of infection by
each virus in dog tracheas, whereas equine viruses were more in-
fectious than canine viruses in horse tracheas (27). However, in
our experiments with pig trachea explants, the replication of Eq
and Ca virus strains was minimal (Tables 3 and 4), indicating that
factors other than sialic acid binding may play a role in infectivity
and host susceptibility.
Altogether, our results indicate that Eq and Ca virus isolates
may have little, if any, capacity to infect pigs, whereas Av and Se
virus isolates retain this ability. This observation was based on
evidence provided by Ito and coworkers showing that the porcine
trachea contains sialic acids with 	-2,6 and 	-2,3 linkages to ga-
lactose (receptors preferred by human and avian IAVs, respec-
tively). However, recent data from Van Poucke et al. showed that
the sialic acid receptor distribution in pig respiratory tissue is sim-
ilar to that in humans, showing abundant expression of 	-2,6-
linked sialic acid receptors in the trachea, as well as in other parts
of the respiratory tract, whereas	-2,3-linked sialic acids were only
detected in the bronchioles and alveoli (28, 29). The similarity in
receptor specificity in humans has been clearly shown with the
novel pandemic H1N1 virus from 2009, whereby a zoonotic event
spread the virus through the human population and reverse zoo-
notic events caused pigs to be infected by human viruses.
In order to prove whether or not these sets of H3N8 virus were
able to infect pigs, an experimental infection was performed. In-
fection took place intratracheally with 2 105 EID50 of each virus.
This infectious dose was dictated by the poor growth of the Ca
virus isolate in embryonated chicken eggs only. In accordance
with our results in vitro, Eq and Ca viruses did not cause lesions,
and they did not replicate in pig lungs, whereas the Av and Se
strains did. Despite a low inoculation dose compared to other
reported experimental infections (12, 28), the Av and Se IAVs
were able to replicate substantially in the lungs of pigs, caused
lesions, andmaintained infection until day 6.However, no clinical
respiratory symptoms were observed, and no virus shedding was
detected in any H3N8 virus-infected pig (Fig. 2), indicating that
horizontal transmission was unlikely to happen in a situation
where these isolates infect pigs. Nevertheless, it cannot be ruled
out that the low dose of inoculum and the administration route
could affect the pattern of clinical outcome and shedding for
H3N8 IAV.
Surprisingly, we could not detect specific antibodies against
HA in anyH3N8-infected pigs even though antibodies against NP
were detected by ELISA. The fact that seroconversion against HA
in the Eq and Ca IAV-infected pigs was not detected could be due
to the absence of replication, but the fact that antibodies to HA
were not detectable in the groups of pigs infected with H3N8
viruses with a bird origin (Av and Se) was an unpredicted event
(Table 7). However, antibodies to NAwere detected at 21 dpi only
in pigs where replication was taking place, such with the Sw, Av,
and Se virus isolates (Fig. 5). To determine whether this lack of
antibody detection by HAI testing was due to a particular host,
immunization experiments were conducted in mice. Similar re-
sults were obtained in mice and pigs, whereby HAI antibodies in
Av and Se virus-infected animals were undetectable, whereas an-
tibodies against IAV were detected (Table 8 and Fig. 6). These
results indicate that the lack of HAI antibodies when pigs were
infected with Av or Se viruses were not due to a particular host. A
similar failure was also observed in experimental infections in pigs
where various swine IAV subtypes were used for intratracheal in-
oculation (30). Therefore, special attention should focus onH3N8
subtype viruses, since they could behave as stealth viruses when
HAI is used as a diagnostic tool in an important host such as swine,
where further adaptation and the acquisition of human-like fea-
tures could take place. Nevertheless, a possible caveat of the pres-
ent study would be that only one H3N8 strain isolated from each
host be used as a representative one.We cannot rule out that other
H3N8 IAV strains could behave differently, and this is an area that
merits further study.
Recently, a live attenuated, cold-adapted H3N8 virus has been
engineered using reverse genetics (31), and the results suggest that
a single dose of this H3N8 vaccine induced a protective response
in mice against homologous and heterologous viruses, including
the SeH3N8 virus used in our study. Serological data fromhuman
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and ferrets also suggest that this H3N8 vaccine may be protective.
It remains to be explored whether this promising vaccine candi-
date would exhibit the same cross-reactivity and protective ability
in pigs, given the ability of certain H3N8 viruses to infect pigs.
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